In the latest trading session,, 3.76 million Clearside Biomedical Inc (NASDAQ:CLSD) shares changed hands as the company’s beta touched 2.06. With the company’s most recent per share price at $0.76 changed hands at -$0.03 or -3.28% at last look, the market valuation stands at $59.12M. CLSD’s current price is a discount, trading about -117.11% off its 52-week high of $1.65. The share price had its 52-week low at $0.70, which suggests the last value was 7.89% up since then.
Analysts gave the Clearside Biomedical Inc (CLSD) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 5 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended CLSD as a Hold, 5 felt it is a Buy and 0 rated the stock as Underweight. Clearside Biomedical Inc’s EPS for the current quarter is expected to be -0.1.
Clearside Biomedical Inc (NASDAQ:CLSD) trade information
Instantly CLSD was in red as seen in intraday trades today. With action 2.81%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -19.93%, with the 5-day performance at 2.81% in the green. However, in the 30-day time frame, Clearside Biomedical Inc (NASDAQ:CLSD) is -10.41% down.
Clearside Biomedical Inc (CLSD) estimates and forecasts
Year-over-year growth is forecast to reach 138.58% up from the last financial year.
Consensus estimates given by 7 financial analysts project the company’s revenue in the current quarter to hit an average of 498.43k. 7 analysts are of the opinion that Clearside Biomedical Inc’s revenue for the current quarter will be 498.57k. The company’s revenue for the corresponding quarters a year ago was 90k and 1.04M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 453.81%. The estimates for the next quarter sales put growth at -51.97%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 10.40%. The 2025 estimates are for Clearside Biomedical Inc earnings to increase by 13.37%, but the outlook for the next 5-year period is at -2.08% per year.
CLSD Dividends
Clearside Biomedical Inc is expected to release its next quarterly earnings report in July.
ROSALIND ADVISORS, INC. holds the second largest percentage of outstanding shares, with 3.4692% or 2.59 million shares worth $3.37 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 1.97 shares estimated at $1.51 million under it, the former controlled 2.54% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 1.01% of the shares, roughly 783.85 shares worth around $0.6 million.
